LEVOCETIRIZINE DIHYDROCHLORIDE

Levocetirizine dihydrochloride is a potent H1antihistamine reducing allergic symptoms. Benefits include minimal sedation. Side effects include drowsiness, dry mouth, and fatigue. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 5b9e77bd8d52 Category: Tag:

Product Description


Mechanism of Action

LEVOCETIRIZINE DIHYDROCHLORIDE demonstrates a highcomplexity biochemical profile involving modulation of receptor systems, enzymeregulated metabolic pathways, mitochondrial performance, intracellular ion dynamics and transcriptionlevel regulation. Its structural properties support binding to catalytic and regulatory protein domains, altering phosphorylation cascades, redoxstate equilibrium, cellular stressresponse thresholds and mitochondrial signalling output.

The molecule may influence calcium flux, ATP turnover, ROSantioxidant balance, cytoskeletal organisation and membranepotential stability depending on the biological system and concentration applied.

Benefits and Advantages

Widely applied in mechanistic and pharmacodynamic research, including:

  • Receptorligand interaction analysis and affinity profiling
  • Enzymekinetic and catalyticpathway investigations
  • Mitochondrialfunction, metabolicflux and oxidativestress studies
  • Multiomics research: transcriptomics, proteomics and metabolomics
  • Cellstress signalling, apoptosis/autophagy modelling and cytoskeletaldynamics mapping
  • Preclinical screening, SAR modelling and comparative mechanistic benchmarking

Side Effects and Risks

Potential risks include oxidative imbalance, mitochondrial strain, unintended receptor crossactivation, ionchannel perturbation, metabolic rewiring, and dosedependent cytotoxicity. High exposure may induce apoptosis, autophagy, inflammatory signalling or transcriptional destabilisation. Strict laboratory safety protocols and controlled handling conditions are required.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C21H27Cl3N2O3

Molecular Weight

461.8 g/mol

CAS Number

130018-87-0

Storage Condition

Store at 20-25 °C (68-77 °F); excursions permitted to 15-30 °C (59-86 °F)

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Levocetirizine dihydrochloride; 130018-87-0; Xyzal; SOD6A38AGA; Xyzal Allergy 24hr

IUPAC/Chemical Name

2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride

InChl Key

PGLIUCLTXOYQMV-GHVWMZMZSA-N

InChl Code

InChI=1S/C21H25ClN2O3.2ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H/t21-;;/m1../s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/9955977;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download